ArticleJournal of bone oncology2022

Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384.

Tao Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.